Abstract:Background/Aims: Cellular hypertrophy is an early important pathological feature of renal diseases such as diabetic nephropathy and remnant kidney. Recent studies have demonstrated that angiotensin II (Ang II) might be a major contributor in regulating cell hypertrophy. However, the exact mechanism is still unclear. The aim of our present work was to investigate the possible role of a newly clarified fibrogenic factor, connective tissue growth factor (CTGF), in mediating the effect of Ang II-induced tubular cell hypertrophy. Methods: The cell line HK2 was grown in Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated fetal calf serum. After the cells were rested in serum-free medium for 24 h, the dose and time response of CTGF mRNA expression to Ang II stimulation was observed by RT-PCR, and protein synthesis was observed by Western blotting. The effect of anti-CTGF on Ang II (10–7M)-induced [3H]-leucine incorporation, total protein content (Coomassie brilliant blue G250 method) and change in cellular size [determined by a scanning electronic microscope (SEM)] was also observed. The influence of anti-CTGF antibody on the cell cycle was analyzed by using a fluorescence-activated cell sorter flow cytometer. Results: The results showed that Ang II induced expression of CTGF mRNA in a time- and dose-dependent manner (p < 0.05 and 0.01, respectively). Stimulation of cells with Ang II (10–7M) for 48 h resulted in a 92% increase in [3H]-leucine incorporation (5,584 cpm/105 cells at 0 h vs. 10,741 cpm/105 cells at 48 h; p = 0.01), which was significantly abolished by treatment with anti-CTGF antibody. Ang II (10–7M) significantly increased the total protein content in HK2 cells (control: 0.169 ± 0.011 mg/105 cells vs. Ang II: 0.202 ± 0.010 mg/105 cells; p = 0.03), which was markedly inhibited by cotreatment with anti-CTGF antibody. The average cellular diameter determined by SEM showed that the increase in cell size induced by Ang II could be significantly inhibited by anti-CTGF antibody (control: 11.92 ± 1.62 µm, Ang II group: 20.63 ± 3.83 µm, Ang II + anti-CTGF group: 16.43 ± 3.23 µm; p < 0.01, respectively). Furthermore, the flow cytometer study showed that Ang II arrested the cell cycle at G0–G1 phase, which was significantly reversed by treatment with anti-CTGF antibody (G0–G1 percentage: in Ang II group: 76 ± 1.8%, in Ang II + anti-CTGF group: 71 ± 1.78%; p = 0.04). Conclusion: Our data are the first to clearly demonstrate that CTGF might be an important mediator of Ang II-induced renal hypertrophy, which suggests that inhibiting the production of CTGF might be the new strategy in early prevention of renal fibrosis.

Angrem104, an Angiotensin Ii-Induced Novel Up-Regulated Gene in Human Mesangial Cells, is Potentially Involved in the Regulation of Fibronectin Expression.

Screening and identification of the up-regulated genes in human mesangial cells exposed to angiotensin II.

Screening for Functional Genes Related to a Novel Gene, AngRem104, in Human Mesangial Cells by Cdna Microarray

The Novel Gene Angrem104 Downregulates Glucocorticoid Receptor Expression and Activates Nf-Kappa B in Human Mesangial Cells

Screening and Identification of the Up-Regulated Genes in Human Mesangial Cells Induced by Angiotensin Ⅱ

AngRem104 potentially regulates the transcription of fibronectin through the activation of promoter

Screening for Genes Related to Novel Gene AngRem104 by Gene Chip

Role Of Aldose Reductase In Tgf-Beta 1-Induced Fibronectin Synthesis In Human Mesangial Cells

Role of aldose reductase in TGF-β1-induced fibronectin synthesis in human mesangial cells

Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.

Effect of High Glucose, Angiotensin II and Receptor Antagonist Losartan on the Expression of Connective Tissue Growth Factor in Cultured Mesangial Cells.

An RNA‑sequencing Study Identifies Candidate Genes for Angiotensin II‑induced Cardiac Remodeling.

EFFECT OF ANGIOTENSIN Ⅱ AND ITS RECEPIOR ANTAGONIST ON EXPRESSION OF CONNECTIVE TISSUEGROWTH FACTOR IN MESANGIAL CELLS

Cellular Repressor of E1A-Stimulated Genes is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II

[Effects of Aldose Reductase on the Transforming Growth Factor-Beta1-induced Expression of Fibronectin and Collagen IV: Experiment with Cultured Rat Mesangial Cells].

Role of Connective Tissue Growth Factor in Mediating Hypertrophy of Human Proximal Tubular Cells Induced by Angiotensin II.

The chromatin remodeling protein BRG1 mediates Ang II induced pro-fibrogenic response in renal fibroblasts

Role of MAPK Signaling Proteins on Expression of Fib Ronectin in Rat Peritoneal Mesothelial Cells Induced by Angiotensin II

Coimmunoprecipitation Analysis of Putative Interaction of Novel Gene AngRem 104 and Glucocorticoid Receptor AF-1 Specific Elongation Factor

[Production of Aldosterone by Rat Mesangial Cell and the Accumulation of Extracellular Matrix Induced by Aldosterone].

Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts